ArticleDrugs in R&D2022

Risk Factors for Septic Shock After Irinotecan-Containing Chemotherapy: An Exploratory Case-Control Study.

Maki Umemiya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.